Neurology CP:心脏骤停和胸外按压期间的脑电图改变

2018-07-17 杨中华 脑血管病及重症文献导读

在进行21导脑电图(EEG)检测时突发室性心动过速(VT)。VT 40秒后EEG记录到高频电活动(higher frequency elements)波幅降低,以前有人认为这个现象发生于心脏停跳30秒以内。胸外按压几秒钟后EEG活动恢复,提示脑灌注增加。

68岁,男性。

在进行21导脑电图(EEG)检测时突发室性心动过速(VT)。VT 40秒后EEG记录到高频电活动(higher frequency elements)波幅降低,以前有人认为这个现象发生于心脏停跳30秒以内。胸外按压几秒钟后EEG活动恢复,提示脑灌注增加。

A图,心律失常前的EEG。B图,发作后40秒可见高频活动弥漫性变慢和减弱:



C图,开始胸部按压。D图,胸部按压期间高频EEG背景活动恢复,并且胸外按压停止后能够维持几秒钟:



最终该患者复苏成功,预后很好。这例患者提示危及生命的心律失常时迅速进行基础生命支持有助于维持脑灌注和代谢。

原始出处:J. Matthijs Biesbroek, Esther M. Hopmans, Antje A. Seeber, Selma C. Tromp. EEG registration during ventricular tachycardia and resuscitation. Neurology Clinical Practice. May 01, 2018

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1651262, encodeId=bcb9165126240, content=<a href='/topic/show?id=6f9c564499c' target=_blank style='color:#2F92EE;'>#按压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56449, encryptionId=6f9c564499c, topicName=按压)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a7424147894, createdName=lisa446, createdTime=Sun Jan 27 19:52:00 CST 2019, time=2019-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2000509, encodeId=7be8200050987, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri May 10 12:52:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630471, encodeId=49d316304e1ca, content=<a href='/topic/show?id=dbd084102dd' target=_blank style='color:#2F92EE;'>#胸外按压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84102, encryptionId=dbd084102dd, topicName=胸外按压)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=082221527772, createdName=dongjia2017, createdTime=Thu Jul 19 07:52:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332278, encodeId=1c103322e8c3, content=好文献学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Tue Jul 17 20:01:41 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332261, encodeId=ce07332261b5, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Tue Jul 17 18:30:55 CST 2018, time=2018-07-17, status=1, ipAttribution=)]
    2019-01-27 lisa446
  2. [GetPortalCommentsPageByObjectIdResponse(id=1651262, encodeId=bcb9165126240, content=<a href='/topic/show?id=6f9c564499c' target=_blank style='color:#2F92EE;'>#按压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56449, encryptionId=6f9c564499c, topicName=按压)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a7424147894, createdName=lisa446, createdTime=Sun Jan 27 19:52:00 CST 2019, time=2019-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2000509, encodeId=7be8200050987, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri May 10 12:52:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630471, encodeId=49d316304e1ca, content=<a href='/topic/show?id=dbd084102dd' target=_blank style='color:#2F92EE;'>#胸外按压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84102, encryptionId=dbd084102dd, topicName=胸外按压)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=082221527772, createdName=dongjia2017, createdTime=Thu Jul 19 07:52:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332278, encodeId=1c103322e8c3, content=好文献学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Tue Jul 17 20:01:41 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332261, encodeId=ce07332261b5, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Tue Jul 17 18:30:55 CST 2018, time=2018-07-17, status=1, ipAttribution=)]
    2019-05-10 yinhl1978
  3. [GetPortalCommentsPageByObjectIdResponse(id=1651262, encodeId=bcb9165126240, content=<a href='/topic/show?id=6f9c564499c' target=_blank style='color:#2F92EE;'>#按压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56449, encryptionId=6f9c564499c, topicName=按压)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a7424147894, createdName=lisa446, createdTime=Sun Jan 27 19:52:00 CST 2019, time=2019-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2000509, encodeId=7be8200050987, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri May 10 12:52:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630471, encodeId=49d316304e1ca, content=<a href='/topic/show?id=dbd084102dd' target=_blank style='color:#2F92EE;'>#胸外按压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84102, encryptionId=dbd084102dd, topicName=胸外按压)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=082221527772, createdName=dongjia2017, createdTime=Thu Jul 19 07:52:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332278, encodeId=1c103322e8c3, content=好文献学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Tue Jul 17 20:01:41 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332261, encodeId=ce07332261b5, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Tue Jul 17 18:30:55 CST 2018, time=2018-07-17, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1651262, encodeId=bcb9165126240, content=<a href='/topic/show?id=6f9c564499c' target=_blank style='color:#2F92EE;'>#按压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56449, encryptionId=6f9c564499c, topicName=按压)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a7424147894, createdName=lisa446, createdTime=Sun Jan 27 19:52:00 CST 2019, time=2019-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2000509, encodeId=7be8200050987, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri May 10 12:52:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630471, encodeId=49d316304e1ca, content=<a href='/topic/show?id=dbd084102dd' target=_blank style='color:#2F92EE;'>#胸外按压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84102, encryptionId=dbd084102dd, topicName=胸外按压)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=082221527772, createdName=dongjia2017, createdTime=Thu Jul 19 07:52:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332278, encodeId=1c103322e8c3, content=好文献学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Tue Jul 17 20:01:41 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332261, encodeId=ce07332261b5, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Tue Jul 17 18:30:55 CST 2018, time=2018-07-17, status=1, ipAttribution=)]
    2018-07-17 张新亮1853311252142e2fm

    好文献学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1651262, encodeId=bcb9165126240, content=<a href='/topic/show?id=6f9c564499c' target=_blank style='color:#2F92EE;'>#按压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56449, encryptionId=6f9c564499c, topicName=按压)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a7424147894, createdName=lisa446, createdTime=Sun Jan 27 19:52:00 CST 2019, time=2019-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2000509, encodeId=7be8200050987, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri May 10 12:52:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1630471, encodeId=49d316304e1ca, content=<a href='/topic/show?id=dbd084102dd' target=_blank style='color:#2F92EE;'>#胸外按压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84102, encryptionId=dbd084102dd, topicName=胸外按压)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=082221527772, createdName=dongjia2017, createdTime=Thu Jul 19 07:52:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332278, encodeId=1c103322e8c3, content=好文献学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Tue Jul 17 20:01:41 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332261, encodeId=ce07332261b5, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Tue Jul 17 18:30:55 CST 2018, time=2018-07-17, status=1, ipAttribution=)]
    2018-07-17 orangesking

    0

相关资讯

Circulation:复苏团队大大影响院内心脏骤停患者预后

院内心脏骤停(IHCA)常见,在美国各医院的预后差别很大,但目前造成上述差异的原因尚不明确。现Brahmajee K. Nallamothu等人探究IHCA预后最好的医院是如何组织其复苏团队获得IHCA的高存活率。研究人员计算了2012年-2014年间在美国心脏协会登记的IHCA患者存活至出院的风险标准化概率。鉴定IHCA患者存活率的上、中、下四分位数中的9家医院的地理和学术差异,进行包含对临床和

美国心脏协会声明:心肺复苏是生活必备技能

美国心脏协会(AHA)近日发表声明指出,改善心肺复苏培训,能救助更多生命。AHA希望,到2020年,心脏骤停生存率,以及第一目击者及时反应率都能翻倍提升。

Neurology:心脏骤停后双侧颞侧新月形视野保留

48岁男性,主诉在经历了心脏骤停院外复苏后出现管状视力。最佳矫正视敏度为20/15(右眼和左眼)。瞳孔反应无殊。

Neurology:小儿心脏骤停后神经结果评估工具研究

研究认为PRCA评分是小儿心脏骤停患者神经学结果描述强有力的方法,为神经功能损伤、领域特异性损伤以及神经行为结果指标之间的相关性研究提供工具

2018 AHA科学声明:复苏教育-改善心脏骤停结局的教育策略

2018年6月,美国心脏协会(AHA)发布了关于复苏教育-改善心脏骤停结局的教育策略的科学声明,本文主要针对关键教育的有效性和地方执行要素的文献信息回顾,对改善心脏骤停患者的措施提出改进建议。

广东中山市人民医院使用ECMO救治心梗心脏骤停经验:联合PCI救治成功率近50%

急性心肌梗死后出现心脏骤停,往往需要先进行心肺复苏后,再行冠脉介入治疗。而急救药物及主动脉内球囊反搏(IABP)等传统的机械循环辅助手段,往往无法维持患者稳定的循环功能,血流动力学不稳定状态可持续恶化,使患者错过行急诊冠脉介入治疗的最佳时机,预后不佳。